* Kalobios receives orphan drug designation for benznidazole in the treatment of chagas disease

* Kalobios Pharmaceuticals Inc - ‍expects to submit a new drug application (nda) submission for benznidazole in q1 of 2018​ Source text for Eikon: Further company coverage: